PARTIAL THROMBOPLASTIN TIME, ANTI-XA, AND LOW-MOLECULAR WEIGHT HEPARIN ADMINISTRATION

被引：0
|
作者：
FREEDMAN, MD
HAYDEN, D
PRASAD, R
LEESE, PT
机构：
[1] SANOFI RES,NEW YORK,NY
[2] QUINCY RES CTR,KANSAS CITY,MO
来源：
CLINICAL RESEARCH | 1989年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A103 / A103
页数：1
相关论文
共 50 条
  • [1] ANTI-XA POTENTIATING EFFECT OF LOW-MOLECULAR WEIGHT HEPARIN
    JUNKER, W
    HARENBERG, J
    FUSSI, F
    MATTES, K
    ZIMMERMANN, R
    WEBER, E
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 235 - 235
  • [2] Correlation between activated partial thromboplastin time and anti-Xa activity in patients who received low-molecular weight heparin as anticoagulation for haemodialysis
    Wong, Steve Siu-Man
    Lau, Wai-Yan
    Chan, Ping-Kwan
    Wan, Ching-Kit
    Cheng, Yuk-Lun
    [J]. NEPHROLOGY, 2017, 22 (11) : 921 - 924
  • [3] PRACTICAL CONSIDERATIONS ON THE MEASUREMENT OF LOW-MOLECULAR WEIGHT HEPARIN ANTI-XA ACTIVITY
    AIACH, M
    RONCATO, M
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (02): : 108 - 111
  • [4] Low-molecular weight heparin (LMWH) in pregnancy: Role of anti-Xa monitoring
    Abu-Hajir, M
    Kuhlmann, RS
    Wigton, TR
    Friedman, KD
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 846 - 846
  • [5] Laboratory Monitoring of Heparin Therapy: Partial Thromboplastin Time or Anti-Xa Assay?
    Lehman, Christopher M.
    Frank, Elizabeth L.
    [J]. LABMEDICINE, 2009, 40 (01): : 47 - 51
  • [6] THE LACK OF RELATIONSHIP BETWEEN ANTI-XA ACTIVITY AND ANTITHROMBOTIC ACTIVITY OF LOW-MOLECULAR WEIGHT HEPARIN
    OCKELFORD, PA
    CARTER, CJ
    HIRSH, J
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 116 - 116
  • [7] INCREASED ANTI-XA BIOAVAILABILITY FOR A LOW-MOLECULAR WEIGHT HEPARIN (PK-10169) COMPARED WITH UNFRACTIONATED HEPARIN
    BARA, L
    BILLAUD, E
    KHER, A
    SAMAMA, M
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (03): : 316 - 317
  • [8] MONITORING AN ANTICOAGULATION USING A LOW-MOLECULAR WEIGHT HEPARIN (HBPM) - SIGNIFICANCE OF THE DOSAGE OF ANTI-XA ACTIVITY
    MASSONNETCASTEL, S
    PELISSIER, E
    TERRIER, E
    JAULMES, B
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1985, 43 (04) : 696 - 696
  • [9] Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring: Biochemical Basis for Discordance
    Takemoto, Clifford M.
    Streiff, Michael B.
    Shermock, Kenneth M.
    Kraus, Peggy S.
    Chen, Junnan
    Jani, Jayesh
    Kickler, Thomas
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (04) : 450 - 456
  • [10] Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis
    Fuentes, Amaris
    Gordon-Burroughs, Sherilyn
    Hall, Jeffrey B.
    Putney, David R.
    Monsour, Howard P., Jr.
    [J]. THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 40 - 44
12345